GEROSCIENCE-DRIVEN THERAPIES TO TARGET HEALTHSPAN WITH AGING: CLINICAL IMPLICATIONS
Sara Espinoza, Mitzi Gonzales, Nicolas Musi · 2024
Read GEROSCIENCE-DRIVEN THERAPIES TO TARGET HEALTHSPAN WITH AGING: CLINICAL IMPLICATIONS by Sara Espinoza, Mitzi Gonzales, Nicolas Musi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11691230.txt.
Description
Sara Espinoza, Mitzi Gonzales, and Nicolas Musi review therapies driven by geroscience, the idea that targeting aging itself can delay many diseases at once. If the hypothesis holds, one intervention could extend healthspan, the years lived free of major disease and disability. Trials of candidate drugs are already underway.
The authors stress what trials must settle beyond safety: which gains in strength, thinking, frailty, and daily life count as success. No single drug will suit everyone, so care will likely be tailored. Larger practical trials must follow early studies. Doctors who are not aging specialists will need training, since most elder care happens outside specialty clinics.
Catalog record
| CREATOR | Sara Espinoza, Mitzi Gonzales, Nicolas Musi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |